Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle recall — FDA D-0648-2024
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Complete FDA and NHTSA recall records dated in 2024, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Failed Dissolution Specifications: below specification results
Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.
Mazda North American Operations (Mazda) is recalling certain 2024 Mazda 3, CX-30, and 2025 CX-50 vehicles. A malfunction in the forward sensing camera (FSC) may prevent the automatic…
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
During sterile barrier testing performed on the decanter product line, the samples were identified to have pin holes and tears in the packaging film.
During sterile barrier testing performed on the decanter product line, the samples were identified to have pin holes and tears in the packaging film.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
Potential for the anti-fall system of the device arm to fail.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
Their is a potential for high background and off-target staining when using the monoclonal primary antibody which can result in false positive results.
During sterile barrier testing performed on the decanter product line, the samples were identified to have pin holes and tears in the packaging film.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
Alcon has detected an increase in complaint reports related to sharpness for specific ClearCut Dual Bevel Sideport and A-OK Comeal/Scleral V-Lance Ophthalmic knives.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
A slight dimensional variation which has the potential for increased difficulty fitting into outer canister.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.